Research progress of novel anti-tumor drug formulations
Cancers have become the second leading cause of death worldwide, following cardiovascular diseases.Traditional anti- cancer strategies, including radiotherapy chemotherapy, surgery, and targeted therapies, have been widely used but are often reassessed due to their significant side effects and relat...
Saved in:
| Main Authors: | Yan Liu, Qie Guo, YunYan Shi, MengNa Cui, FanBo Jing |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1507958/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research Progress on Peptide Drugs for Type 2 Diabetes and the Possibility of Oral Administration
by: Xinxin Yang, et al.
Published: (2024-10-01) -
Classification of Nanomaterial Drug Delivery Systems for Inflammatory Bowel Disease
by: Wang H, et al.
Published: (2025-02-01) -
Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance
by: Wenjun Meng, et al.
Published: (2024-12-01) -
A Systematic Review of Spironolactone Nano-Formulations for Topical Treatment of Skin Hyperandrogenic Disorders and Chronic Wounds
by: Saedah Dereiah, et al.
Published: (2024-12-01) -
The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice
by: Amin Mehrabian, et al.
Published: (2023-04-01)